The world's first RWA building lands in Nanjing! Why does IVD MEDICAL (01931) dare to be a "pioneer" in eating crab?

On September 19, IVD MEDICAL (01931) released a major announcement, announcing two strategic actions: the official completion of the world's first research and development base focusing on Real World Assets (RWA) digital technology - the ETHK Building (also known as the IVD MEDICAL Building) in Nanjing, and a comprehensive update of the company's logo. This is not only a brand upgrade, but also a key milestone for IVD MEDICAL's transformation into a "global digital industry innovation and blockchain financial infrastructure enabler". 1. Physical and Digital Integration: The Technological Ambition of the ETHK Building The ETHK Building is located in the Jianye District of Nanjing, with a total construction area of approximately 70,000 square meters. It is far from being a typical commercial property, but rather the physical core of IVD MEDICAL's "ETHK blockchain financial ecosystem strategy". According to the announcement, the building will have two main missions: First, to serve as a physical research and collaborative innovation infrastructure, bringing together over 5000 technical experts and ecological partners, and providing world-class laboratories, data centers, and testing environments. Second, to serve as a trusted technology research and output base, integrating full-stack capabilities such as blockchain underlying research, smart contract security auditing, cross-chain protocols, and regulatory technology (RegTech). The completion of the building marks IVD MEDICAL's transition from "conceptual leadership" to the "large-scale physical implementation" phase. Its significance lies not only in the expansion of physical space, but also in the expression of the integration of technological capabilities and ecological synergy. On September 22, IVD MEDICAL will hold the world's first RWA technology base completion ceremony at the ETHK Building, which is not only the official announcement of the use of this physical technology asset, but also an important opportunity to showcase the solid implementation of the IVD MEDICAL "ETHK blockchain financial ecosystem strategy" to the global market. 2. Why dare to be a "trailblazer"? The Triple Dividend of Policy, Technology, and Ecology IVD MEDICAL's bold layout of RWA physical infrastructure is based on in-depth analysis of technological trends, policy dividends, and market demand. At the technological level, RWA (Real World Asset) refers to "tokenizing real-world assets", converting physical assets (such as real estate, intellectual property, financial assets) into digital assets on the blockchain to increase liquidity and reduce transaction costs. According to Defillama data, as of June 2025, the total locked value (TVL) of global RWA has reached $12.5 billion, a year-on-year increase of 124%. IVD MEDICAL has built a full-chain capability covering technology infrastructure, asset issuance, and compliance operations through its joint venture companies ETHK Inc. and ETHK HOLDINGS LIMITED. At the policy level, regulatory frameworks at home and abroad are gradually becoming clearer. The SEC and CFTC in the United States jointly supported the registration of platforms to conduct cryptocurrency spot trading on September 3, with the SEC chairman explicitly stating that "most cryptocurrencies are not securities"; Hong Kong issued the "Digital Asset Development Policy Declaration 2.0", listing RWA as an important support point for digital economy development; and the Jiangsu Free Trade Zone in China has also been approved to carry out an open innovation pilot for the full industry chain of biomedicine, providing a policy environment for the application of RWA in the field of pharmaceutical assets. At the market level, there is a strong contrast between the liquidity constraints of traditional assets and the demands of the digital economy. Taking Renhe Pharmacy (000650.HK) subsidiary Renhe International, a partner of IVD MEDICAL, as an example: its net profit in the first half of 2025 decreased by 13.87% year-on-year, facing growth pressure. By tokenizing RWA, Renhe Pharmacy can activate well-known IP assets such as "Fuyan Jie" and "Yukadan", connect with global capital, and open up new growth curves. Such demand is widespread in areas such as energy, agriculture, and supply chains. IVD MEDICAL's pioneering advantage lies in its deep integration of medical industry experience, blockchain technology capabilities, and compliance architecture, forming an innovative model of "physical + technology + finance". 3. Aim high and strike hard: Building a moat to help Chinese assets "go global on the chain" IVD MEDICAL's layout of RWA is not a short-term capital story, but a long-term strategic investment. Its core value is reflected in two aspects: First, building a super high moat. Through the physical investment, technological research and development, and ecological aggregation of the ETHK Building, IVD MEDICAL has established a fourfold barrier of "technology + license + assets + partners". Its strategic cooperation with Renhe International has already verified the replicability of the "ETHK global RWA trading platform". According to the announcement, IVD MEDICAL holds 5190 ETH as a reserve in its treasury, and plans to further increase its holdings, demonstrating its long-term confidence in the blockchain financial ecosystem. Second, empowering the globalization of Chinese assets. IVD MEDICAL's vision is to help high-quality Chinese assets achieve "going global on the chain" through RWA technology, obtaining global pricing and financing. For example, the global first OTC vertical area RWA exchange jointly built with Renhe International can not only promote the China Meheco Group brand to the world, but also introduce innovative products from overseas, creating a two-way empowerment. Behind this strategy is the altruistic concept of "technology serving the public, blockchain carrying the road". IVD MEDICAL has repeatedly emphasized "utmost altruism" in its announcement, aiming to lower the financing costs of physical industries and improve asset liquidity through technological innovation, ultimately benefiting consumers and the public interest. As the announcement states, "Let cutting-edge financial technology benefit a broader range of industries and people." 4. A blockchain revolution from Nanjing to the world IVD MEDICAL's transformation and investment is a typical example of a Chinese company seizing the high ground of digital financial infrastructure. On the eve of the trillion-dollar RWA race, with a physical technology base as its anchor and ecological cooperation as its sail, IVD MEDICAL demonstrates rare strategic determination and execution. The competition in global digital finance is just beginning. With technology maturity and regulatory clarity, RWA is expected to become a key bridge connecting the real economy and the crypto world. IVD MEDICAL's "crab feast" may become an important chapter in the narrative of Chinese asset globalization. Overall, the announcement discusses IVD MEDICAL's strategic moves towards digitalization and the development of RWA technology, highlighting the company's focus on innovation, technology development, and global expansion.